Patents Assigned to HAIKOU QILI PHARMACEUTICAL CO., LTD.
  • Use of recombinant human calcineurin B subunit
    Patent number: 10646553
    Abstract: Provided is a use of a recombinant human calcineurin B subunit (rhCNB) in the preparation of a medicine for killing and/or inhibiting the gastric cancer.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: May 12, 2020
    Assignee: HAIKOU QILI PHARMACEUTICAL CO., LTD.
    Inventors: Kesheng Han, Jian Fu, Zongwen Huang, Shuhong Tian, Lifang Han
  • USE OF RECOMBINANT HUMAN CALCINEURIN B SUBUNIT
    Publication number: 20180311320
    Abstract: Provided is a use of a recombinant human calcineurin B subunit (rhCNB) in the preparation of a medicine for killing and/or inhibiting the gastric cancer.
    Type: Application
    Filed: June 27, 2018
    Publication date: November 1, 2018
    Applicant: HAIKOU QILI PHARMACEUTICAL CO., LTD.
    Inventors: Kesheng HAN, Jian FU, Zongwen HUANG, Shuhong TIAN, Lifang HAN